You are here

  • Home
  • Archive
  • Volume 73, Issue Suppl 2
  • SAT0214 Statistical Evalution of Joint Damage Prgression in Patients with Rheumatoid Arthritis Treated with Infliximab or Biosimilar Infliximab (CT-P13) Anti-TNF Therapy: A Role of Sensitivity Analysis for Missing Data Evaluating Similarity

Article metrics

Article menu
Download PDFPDF
EULAR 2014: Scientific Abstracts
Poster Presentations. Diagnostics and imaging procedures
SAT0214 Statistical Evalution of Joint Damage Prgression in Patients with Rheumatoid Arthritis Treated with Infliximab or Biosimilar Infliximab (CT-P13) Anti-TNF Therapy: A Role of Sensitivity Analysis for Missing Data Evaluating Similarity

 

Online download statistics by month:

Online download statistics by month: June 2014 to December 2023

AbstractFullPdf
Jun 2014500
Jul 20141501
Aug 2014602
Sep 2014800
Oct 20141100
Nov 2014901
Dec 20141903
Jan 2015700
Feb 20152804
Mar 2015801
Apr 20151400
May 2015301
Jun 20151201
Jul 20151800
Aug 20151600
Sep 20151000
Oct 2015400
Nov 2015601
Dec 2015600
Jan 2016700
Feb 2016504
Mar 20161601
Apr 20161201
May 2016800
Jun 20162101
Jul 20161900
Aug 2016700
Sep 2016600
Oct 2016500
Nov 2016400
Dec 2016400
Jan 2017800
Feb 2017602
Mar 2017801
Apr 2017500
May 2017300
Jun 20171200
Jul 2017602
Aug 20171001
Sep 20171600
Oct 2017400
Nov 2017400
Dec 20171200
Jan 20181000
Feb 2018201
Mar 2018800
Apr 20181000
May 20181801
Jun 2018200
Jul 2018200
Aug 2018600
Sep 20181001
Oct 2018600
Nov 2018200
Dec 2018200
Apr 2019400
May 2019400
Jun 2019200
Nov 2019600
Feb 2020200
Apr 2020100
Jun 2020700
Jul 2020200
Sep 2020801
Oct 2020200
Nov 2020200
Dec 2020600
Jan 2021400
Mar 2021100
Apr 2021200
Jun 2021100
Aug 2021100
Sep 2021100
Oct 2021400
Nov 2021601
Dec 2021600
Jan 2022200
Feb 2022400
Mar 2022800
Apr 2022400
May 2022400
Jul 20221200
Aug 20221000
Sep 2022200
Oct 20221403
Nov 20221000
Dec 2022600
Feb 2023900
Mar 2023200
Apr 2023400
May 2023200
Jul 2023200
Sep 2023400
Oct 2023200
Dec 20231400
Total678036